Capital expenditure · 2020–2021
Xeris Biopharma capital expenditure
$1.1M+187.8% · FY2021
Xeris Biopharma (XERS) reported $1.1M in capital expenditure for fiscal 2021, +187.8% year on year.
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2020–2021 compound annual growth +187.8%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Xeris Biopharma capital expenditure |url=https://companiesranked.com/en/company/xeris-biopharma/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Xeris Biopharma capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/xeris-biopharma/capital-expenditureBibTeX
@misc{companiesranked-en-company-xeris-biopharma-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Xeris Biopharma capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/xeris-biopharma/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.